FDA narrowly defines the ability of compounders to make approved medicines
(By Ed Silverman for STAT) In its latest to bid to set parameters around compounding, the US Food and Drug
Read More
Part D/Prescription Drugs
A Fair Plan For Fairer Drug Prices
(By Scott Gottlieb and Kavita Patel for Health Affairs Blog posted July 11, 2016) As the biological basis of more
Read MoreSounds Like A Good Idea? Regulating Drug Prices
(By Julie Rovner and Francis Ying for Kaiser Health News) This is the second in a series of videos about
Read More10 Essential Facts About Medicare and Prescription Drug Spending
(The Henry J. Kaiser Family Foundation, July 7, 2016) Prescription drugs play an important role in medical care for 57
Read MoreWHO (World Health Organization) Wants Fair Drug Pricing
Over the next year, the World Health Organization wants to develop a model for fair drug pricing; one which will
Read MoreAMAC: New Effort to Make Lifesaving Pharmaceuticals Affordable and Available
A newly proposed bill would make it easier for generic drug makers to produce affordable, lifesaving pharmaceuticals. And, the Association
Read MoreLawmakers Urging Approval of Generic Versions of Crestor
US Senator Bernie Sanders and other lawmakers are urging US Food and Drug Administration to approve generic versions of Crestor
Read MoreMedical Marijuana Linked To Modest Budget Benefits For Medicare Part D, Study Finds
(By Shefali Luthra for Kaiser Health News) Prescription drug prices are up, making policy experts increasingly anxious. But relief could
Read MoreStudy: Brand-Name Drugs’ High Copays Soak Medicare Part D Patients
(By Rachel Bluth for Kaiser Health News) A new study takes a fresh measure of generic drugs’ price advantages, revealing
Read MoreHHS announces new actions to combat opioid epidemic
(Source – www.hhs.gov) U.S. Health and Human Services (HHS) Secretary Sylvia M. Burwell today announced several new actions the department
Read More